BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15304523)

  • 1. Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity.
    Fishel ML; Newell DR; Griffin RJ; Davison R; Wang LZ; Curtin NJ; Zuhowski EG; Kasza K; Egorin MJ; Moschel RC; Dolan ME
    J Pharmacol Exp Ther; 2005 Jan; 312(1):206-13. PubMed ID: 15304523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of GADD34 in modulation of cisplatin cytotoxicity.
    Fishel ML; Rabik CA; Bleibel WK; Li X; Moschel RC; Dolan ME
    Biochem Pharmacol; 2006 Jan; 71(3):239-47. PubMed ID: 16325149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.
    Fishel ML; Delaney SM; Friesen LD; Hansen RJ; Zuhowski EG; Moschel RC; Egorin MJ; Dolan ME
    Mol Cancer Ther; 2003 Jul; 2(7):633-40. PubMed ID: 12883036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.
    Fishel ML; Gamcsik MP; Delaney SM; Zuhowski EG; Maher VM; Karrison T; Moschel RC; Egorin MJ; Dolan ME
    Cancer Chemother Pharmacol; 2005 Apr; 55(4):333-342. PubMed ID: 15723259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.
    Rabik CA; Fishel ML; Holleran JL; Kasza K; Kelley MR; Egorin MJ; Dolan ME
    J Pharmacol Exp Ther; 2008 Nov; 327(2):442-52. PubMed ID: 18664592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2.
    Harrison LR; Ottley CJ; Pearson DG; Roche C; Wedge SR; Dolan ME; Newell DR; Tilby MJ
    Biochem Pharmacol; 2009 May; 77(10):1586-92. PubMed ID: 19426695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T; Yang JL; Price JO; Arteaga CL
    Exp Cell Res; 1998 Dec; 245(2):350-9. PubMed ID: 9851876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
    Kuang J; He G; Huang Z; Khokhar AR; Siddik ZH
    Clin Cancer Res; 2001 Nov; 7(11):3629-39. PubMed ID: 11705886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of O6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cells.
    Cai Y; Ludeman SM; Wilson LR; Chung AB; Dolan ME
    Mol Cancer Ther; 2001 Nov; 1(1):21-8. PubMed ID: 12467235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All trans retinoic acid enhances CDDP-induced apoptosis: modulation of the CDDP effect on cell cycle progression.
    Jozan S; Paute S; Courtade-Saïdi M; Julié S; Vidal S; Bugat R; Valette A
    Int J Oncol; 2002 Jun; 20(6):1289-95. PubMed ID: 12012012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monosaccharide-linked inhibitors of O(6)-methylguanine-DNA methyltransferase (MGMT): synthesis, molecular modeling, and structure-activity relationships.
    Reinhard J; Hull WE; von der Lieth CW; Eichhorn U; Kliem HC; Kaina B; Wiessler M
    J Med Chem; 2001 Nov; 44(24):4050-61. PubMed ID: 11708909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.
    Smith SM; Ludeman SM; Wilson LR; Springer JB; Gandhi MC; Dolan ME
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):291-302. PubMed ID: 12845477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor.
    Davies TG; Bentley J; Arris CE; Boyle FT; Curtin NJ; Endicott JA; Gibson AE; Golding BT; Griffin RJ; Hardcastle IR; Jewsbury P; Johnson LN; Mesguiche V; Newell DR; Noble ME; Tucker JA; Wang L; Whitfield HJ
    Nat Struct Biol; 2002 Oct; 9(10):745-9. PubMed ID: 12244298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats.
    Wali RK; Skarosi S; Hart J; Zhang Y; Dolan ME; Moschel RC; Nguyen L; Mustafi R; Brasitus TA; Bissonnette M
    Carcinogenesis; 1999 Dec; 20(12):2355-60. PubMed ID: 10590233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines.
    Jean-Claude BJ; Mustafa A; Watson AJ; Damian Z; Vasilescu D; Chan TH; Leyland-Jones B
    J Pharmacol Exp Ther; 1999 Feb; 288(2):484-9. PubMed ID: 9918549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.
    Mühlhausen U; Schirrmacher R; Piel M; Lecher B; Briegert M; Piee-Staffa A; Kaina B; Rösch F
    J Med Chem; 2006 Jan; 49(1):263-72. PubMed ID: 16392811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.
    Neville K; Blaney S; Bernstein M; Thompson P; Adams D; Aleksic A; Berg S
    Clin Cancer Res; 2004 Aug; 10(15):5072-5. PubMed ID: 15297409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
    J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.